Treo Ventures

Treo Ventures is a specialized firm based in Dublin backing advanced clinical-stage medical technologies and therapeutic interventions in Ireland and the United States. The team focuses on medical devices, diagnostics, and biotech opportunities that have moved past early proof-of-concept and have real clinical evidence, regulatory strategy, and commercial pathway in view. Treo positions itself as a transatlantic partner, leveraging the Irish life sciences manufacturing base and US clinical and capital ecosystems.

The firm invests at Series A and Series B, with checks in the $1M to $5M range, typically participating in syndicates rather than leading large rounds solo. Geographic focus spans Ireland and the US, with a willingness to look at UK and continental European deals where the science fits the mandate.

Founders should arrive with clinical data, a clear regulatory and reimbursement plan, and a syndicate strategy that explains how Treo’s check unlocks the broader round. Limited public information is available on the firm’s full portfolio, so warm introductions through Irish life sciences operators, transatlantic clinical advisors, or co-investors are the most reliable path in. Expect detailed clinical and commercial diligence.